2022³â ´ëÇÑ»ý½Ä¸é¿ªÇÐȸ Á¤±â Çмú´ëȸ : 2022-12-04±³À°ÀÏÀÚ : 2022-12-04
±³À°Àå¼Ò : ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦
±³À°ÁÖÁ¦ :
2022³â ´ëÇÑ»ý½Ä¸é¿ªÇÐȸ Á¤±â Çмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑ»ý½ÄÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ»ý½Ä¸é¿ªÇÐȸ
´ã´çÀÚ : À̽¾Ö
¿¬¶ôó : 02-6956-7967
À̸ÞÀÏ :
office@the-ksri.org ±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 09:00~09:10 Xylitol Inhibits NLRP3 lnflammasome Activity by Fusobacterium Nucleatum Infection and Reduces Preterm Birth ³ëÀÇÁ¤(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 09:10~09:20 Dysfunction of Decidual Lymphatic Endothelial Cells and Immune Regulation in Severe Preeclampsia ÀÌ¿¹Áö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 09:20~09:30 Effects of Conditioned Media from Polarized Macrophages on Mouse Pre-implantation Embryonic Development and Outgrowth of Blastocysts ÃÖÁ¤¿ø(À»Áö´ë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 09:30~09:40 Application of CRISPR RNP with Electroporation and AAV Donor Infection to Generate Conditional Mutant Mice of Elk-3 ¹ÚÇö¼±(Â÷ÀÇ°úÇдë)
Åä·Ð 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 09:40~09:50 Åä·Ð ()
ÈÞ½Ä 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 09:50~10:10 ÈÞ½Ä ()
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 10:10~10:30 Strategies for Treatment of Refractory Infertility ±è¿ëÁø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 10:30~10:50 The Strategy of Ovarian Follicular in Vitro Maturation in Nonhuman Primate Model ±èÀ±¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 10:50~11:10 Various Endometrial Stem Cells-based Therapeutic Approaches for Endometrial Receptivity È«Àμ±(°¡ÃµÀÇ´ë)
Åä·Ð 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 11:10~11:25 Åä·Ð ()
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 11:25~11:55 Regulation of Blood Testis Barrier °è¸íÂù(ÇѾç´ë)
Åä·Ð 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 11:55~12:05 Åä·Ð ()
½Ä»ç 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 12:05~13:00 ½Ä»ç ()
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 13:00~13:20 Role of Regulatory T Cells During Pregnancy ÇÑÀç¿ø(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 13:20~13:40 Macrophage Polarization in Physiological and Pathological Pregnancy ¼ÀÎö(°æºÏÀÇ´ë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 13:40~14:00 Decidual Natural Killer Cells and the Immune Microenvironment at the Maternal-fetal Interface ÇѾֶó(Â÷ÀÇ´ë)
Åä·Ð 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 14:00~14:15 Åä·Ð ()
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 14:15~14:35 Immulological Chages in Endometriosis ±¸È¼±(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 14:35~14:55 Application of Platelet-rich Plasma in Reproduction ÀÌÁ¤·Ä(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 14:55~15:15 Management of Autoimmue Disease in Reproductive Age Women ³²¾ðÁ¤(°æºÏÀÇ´ë)
Åä·Ð 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 15:15~15:30 Åä·Ð ()
ÈÞ½Ä 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 15:30~15:50 ÈÞ½Ä ()
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 15:50~16:10 Intraamniotoic Inflammation and Pregnancy Outcome ¿À°æÁØ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 16:10~16:30 Effect of Oxidative Stress and Inflammation on Adverse Pregnancy Outcomes Á¶Èñ¿µ(Â÷ÀÇ´ë)
±³À°½Ã°£ 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 16:30~16:50 Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome ±èÀº³ª(°í·ÁÀÇ´ë)
Åä·Ð 12-04 ¼¿ï´ëÇб³ CMI ¼¼ºÈ¯ ¿¬±¸È¦ 16:50~17:05 Åä·Ð ()